Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson’s Disease Patients – BioSpace

Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson’s Disease Patients – BioSpace
Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients  BioSpacePublished: Apr 30, 2019. Company on track to report top-line data in July/August time frame. JERUSALEM, April 30, 2019 /PRNewswire/ -- Intec Pharma Ltd. ... read more
Source: Google NewsPublished on 2019-04-30